Detalhe da pesquisa
1.
Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge.
Thromb J
; 9(1): 15, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21995820
2.
A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease.
Expert Rev Hematol
; 12(5): 311-323, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955381
3.
Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status.
Expert Rev Hematol
; 12(5): 295-309, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925855
4.
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study.
Leuk Lymphoma
; 59(9): 2075-2084, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29295653
5.
Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.
Clin Ther
; 39(1): 178-189.e5, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062113
6.
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.
Clin Ther
; 25(7): 2102-19, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12946554
7.
Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs.
Am J Manag Care
; 18(6): 294-302, 2012 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22774997
8.
Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
Pharmacoeconomics
; 30(2): 87-101, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22187932
9.
Anticoagulation Bridging Therapy Patterns in Patients Undergoing Total Hip or Total Knee Replacement in a US Health Plan: Real-World Observations and Implications.
Am Health Drug Benefits
; 4(4): 240-8, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25126354
10.
Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
Expert Rev Pharmacoecon Outcomes Res
; 11(3): 299-306, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671699
11.
Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery.
Curr Med Res Opin
; 27(2): 423-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21192759
12.
An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
J Med Econ
; 14(2): 238-44, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385145
13.
Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
J Med Econ
; 14(6): 824-34, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023098
14.
Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Am J Health Syst Pharm
; 67(17): 1438-45, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20720243
15.
Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients.
Am J Manag Care
; 16(11): 857-63, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21348557
16.
Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.
J Rheumatol
; 32(5): 811-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15868614
17.
Comparison of measured utility scores and imputed scores from the SF-36 in patients with rheumatoid arthritis.
Med Care
; 43(1): 79-87, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15626937
18.
Mapping the SF-12 to the HUI3 and VAS in a managed care population.
Med Care
; 42(9): 927-37, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15319619
19.
Development of a new instrument for rheumatoid arthritis: the Cedars-Sinai Health-Related Quality of Life instrument (CSHQ-RA).
Arthritis Rheum
; 49(1): 78-84, 2003 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12579597